Contact Us
Get in touch
Have questions, want to try the device, or speak to medical? Fill in the below form and our team will get back to you shortly.
For the first time, eye care professionals can offer patients a clinically validated, non-invasive treatment that delivers measurable improvements in vision.
Wong et al., The Lancet Global Health; Global Burden of Disease
Every day, you diagnose patients with dry AMD and have little to offer beyond monitoring and lifestyle guidance. Patients leave your clinic asking:
“Is there anything that can help?”
“Will my vision keep getting worse?”
Until now, the answer has been limited. MacuMira changes that.
MacuMira is a non-invasive medical device that delivers precisely controlled microcurrent stimulation to the retina.
This stimulation targets retinal pigment epithelium (RPE) cells, enhancing mitochondrial activity and supporting cellular function, resulting in measurable improvements in visual acuity.
Randomized, prospective, sham-controlled clinical study.
The Science
MacuMira targets a key root cause of dry AMD: a breakdown in the retina’s energy system.
In a healthy eye, photoreceptors rely on a constant supply of energy to function. This energy is produced through a delicate metabolic balance between photoreceptors and supporting cells in the retina. Over time, in dry AMD, this system begins to fail. Mitochondria, the “batteries” of the cell, become less efficient, energy production drops, and harmful oxidative stress increases.
MacuMira uses low-level microcurrent stimulation to address this directly at the cellular level.
By delivering gentle electrical currents that mimic the body’s natural bioelectric signals, MacuMira helps restore mitochondrial function. This improves the cell’s ability to produce energy (ATP), reduces oxidative stress, and supports the normal metabolic relationship between retinal cells.
In simple terms, MacuMira helps “recharge” the retina — supporting cells that are still alive but not functioning optimally.
Unlike treatments that focus only on slowing structural damage, MacuMira is designed to improve how patients actually see and function in their daily lives.
Why Clinics Choose MacuMira
Join hundreds of practices that are transforming their dry AMD care offering and delivering real results to patients.
How It Works
From onboarding to ongoing treatment, every step is designed for simplicity, safety, and measurable outcomes.
One of our certified MacuMira trainers will visit you for a half-day of hands-on training. By end of day, your team will be ready to provide treatment to patients.
MacuMira integrates smoothly into your existing patient flow. Straightforward protocols and intuitive operation get your team up to speed quickly.
Stimulation of RPE cells enhances mitochondrial ATP formation, leading to improved cellular function and measurable vision improvements.
Improvements from the initial 10-day loading phase can be maintained with one treatment every 3 months.
Real Stories
See the difference MacuMira is making, in clinics and in lives.
Provider Testimonials
Patient Testimonials
Contact Us
Have questions, want to try the device, or speak to medical? Fill in the below form and our team will get back to you shortly.
Questions